Literature DB >> 6816244

Studies of the mechanism of chloroquine binding to synthetic DOPA-melanin.

K B Stepień, T Wilczok.   

Abstract

In order to elucidate the mechanism of drugs binding to melanin, effects of pH, ionic strength and organic solvent on the interaction of chloroquine with synthetic dopa-melanin were studied. The results indicate that electrostatic, hydrophobic and van der Waals' forces participate in the formation of the chloroquine-melanin complex. Binding analysis by the Scatchard method showed that two classes of binding sites take part in the complex formation: strong binding sites with the association constant k1 approximately to 10(5) and weak binding sites with K2 approximately 10(4). Experiments with chemically modified melanin yielded some information about binding sites of this biopolymer. The obtained results suggest that strong binding involves both hydrophobic interaction and electrostatic attraction between the protonated ring system of chloroquine and the ortho-semiquinone groups of melanin. However, the weakly reacting sites can be identified as ionic bonds between protonated aliphatic nitrogen of chloroquine molecule and carboxyl groups of melanin. Van der Waals' forces occurring at the conjunctions of the aromatic rings of the drug and the aromatic indole-nuclei of the melanin probably take part in the weak binding too.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6816244     DOI: 10.1016/0006-2952(82)90612-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]pyridinium ion (HPP+), a metabolite of haloperidol, to synthetic melanin: implications for the dopaminergic neurotoxicity of HPP+.

Authors:  Hidekazu Kawashima; Yasuhiko Iida; Youji Kitamura; Hideo Saji
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

2.  Investigation by NMR spectroscopy of the interaction between synthetic soluble (-)-dopa melanin and drugs.

Authors:  M M Salazar-Bookaman; J Fowble; P Weber; P N Patil
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

3.  A Population Pharmacokinetic Analysis of Dextroamphetamine in the Plasma and Hair of Healthy Adults.

Authors:  Jessica K Roberts; Sarah F Cook; Chris Stockmann; Douglas E Rollins; Diana G Wilkins; Catherine M T Sherwin
Journal:  Clin Drug Investig       Date:  2015-10       Impact factor: 2.859

4.  Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve.

Authors:  Rajendra S Kadam; Uday B Kompella
Journal:  J Pharmacol Exp Ther       Date:  2009-11-19       Impact factor: 4.030

5.  Investigation by imaging mass spectrometry of biomarker candidates for aging in the hair cortex.

Authors:  Michihiko Luca Waki; Kenji Onoue; Tsukasa Takahashi; Kensuke Goto; Yusuke Saito; Katsuaki Inami; Ippei Makita; Yurika Angata; Tomomi Suzuki; Mihi Yamashita; Narumi Sato; Saki Nakamura; Dai Yuki; Yuki Sugiura; Nobuhiro Zaima; Naoko Goto-Inoue; Takahiro Hayasaka; Yutaka Shimomura; Mitsutoshi Setou
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

Review 6.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Authors:  K D Rainsford; Ann L Parke; Matthew Clifford-Rashotte; W F Kean
Journal:  Inflammopharmacology       Date:  2015-08-06       Impact factor: 5.093

7.  Chloroquine and hydroxychloroquine binding to melanin: Some possible consequences for pathologies.

Authors:  R L Schroeder; J P Gerber
Journal:  Toxicol Rep       Date:  2014-11-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.